Get started
GGG

GlucoTrack, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with GlucoTrack, Inc.



Key stats


Market capitalization
‪2.65 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−180.43 USD
Net income (FY)
‪−19.39 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪677.01 K‬
Beta (1Y)
2.86

Employees


Employees (FY)
15
Change (1Y)
+4+36.36%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.29 M‬ USD

Company info


Sector
Health Technology
Industry
Medical Specialties
CEO
Erik Emerson
Website
glucotrack.com
Headquarters
Rutherford
Founded
2001
ISIN
US45824Q8877
CUSIP
45824Q887
FIGI
BBG0025SKQ53
Identifiers
ISIN US45824Q8877
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of GCTK is 2.98 USD — it has decreased by −10.24% in the past 24 hours. Watch GlucoTrack, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GlucoTrack, Inc. stocks are traded under the ticker GCTK.
GCTK stock has fallen by −29.05% compared to the previous week, the month change is a −63.12% fall, over the last year GlucoTrack, Inc. has showed a −95.86% decrease.
GCTK reached its all-time high on Jul 22, 2013 with the price of 11,699,980.50 USD, and its all-time low was 3.75 USD and was reached on Jul 29, 2026. View more price dynamics on GCTK chart.
See other stocks reaching their highest and lowest prices.
GCTK stock is 12.54% volatile and has beta coefficient of 2.86. Track GlucoTrack, Inc. stock price on the chart and check out the list of the most volatile stocks — is GlucoTrack, Inc. there?
Today GlucoTrack, Inc. has the market capitalization of ‪2.38 M‬, it has decreased by −13.53% over the last week.
Yes, you can track GlucoTrack, Inc. financials in yearly and quarterly reports right on TradingView.
GCTK net income for the last quarter is ‪−3.81 M‬ USD, while the quarter before that showed ‪−4.33 M‬ USD of net income which accounts for 0.00% change. Track more GlucoTrack, Inc. financial stats to get the full picture.
No, GCTK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 5, 2026, the company has 15 employees. See our rating of the largest employees — is GlucoTrack, Inc. on this list?
Like other stocks, GCTK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlucoTrack, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlucoTrack, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlucoTrack, Inc. stock shows the sell signal. See more of GlucoTrack, Inc. technicals for a more comprehensive analysis.